Loading...
Castration-Resistant Prostate Cancer: Targeted Therapies and Individualized Treatment
Various molecular mechanisms have been implicated in the progression from hormone-sensitive to castration-resistant prostate cancer (CRPC). Novel targeted agents to treat CRPC have been developed that inhibit either androgen receptor (AR)-mediated signaling (AR antagonists and inhibitors of androgen...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
AlphaMed Press
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3228103/ https://ncbi.nlm.nih.gov/pubmed/21339259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2010-0216 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|